Forian (NASDAQ:FORA) Stock Price Up 8.4% – Here’s Why

Forian Inc. (NASDAQ:FORAGet Free Report)’s share price traded up 8.4% during mid-day trading on Wednesday . The stock traded as high as $2.67 and last traded at $2.33. 88,575 shares were traded during mid-day trading, an increase of 350% from the average session volume of 19,704 shares. The stock had previously closed at $2.15.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reiterated a “buy” rating and set a $5.00 price objective on shares of Forian in a research note on Thursday, November 14th.

Read Our Latest Research Report on FORA

Forian Stock Performance

The firm has a fifty day moving average price of $2.08 and a 200 day moving average price of $2.21. The stock has a market cap of $72.27 million, a PE ratio of -25.89 and a beta of 1.05.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Forian stock. Elser Financial Planning Inc purchased a new position in shares of Forian Inc. (NASDAQ:FORAFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 558,617 shares of the company’s stock, valued at approximately $1,151,000. Elser Financial Planning Inc owned about 1.80% of Forian as of its most recent SEC filing. 19.25% of the stock is owned by institutional investors and hedge funds.

Forian Company Profile

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Featured Stories

Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.